Drug Profile
SGX 523
Alternative Names: SGX-70329; SGX029; SGX523Latest Information Update: 20 May 2008
Price :
$50
*
At a glance
- Originator SGX Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action Proto-oncogene protein c-met inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours